Yükleniyor... / Loading...
This study examined the metabolic effects of different doses of Chardonnay grape marc powder and placebo in overweight people with elevated blood lipid levels (dyslipidemia). It enrolled participants with a body mass index between 25 and 40 who had certain elevated blood lipid values. It was conducted as a study without an assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * BMI ≥ 25 and \< 40 kg/m2 * Dyslipidemia as defined as (any one or all of the following values): * Total cholesterol \> 190 mg/dL but \< 240 mg/dL * LDL-cholesterol \> 130 mg/dL but \< 160 mg/dL * HDL-cholesterol \< 40 mg/dL (men)/\<50 mg/dL (women) * Fasting triglycerides \> 150 mg/dL but \< 300 mg/dL Exclusion Criteria: * Renal, cardiovascular, gastrointestinal or hepatic disease, by medical history * History of a previous cardiovascular event * Diagnosis of type 2 diabetes * Pregnancy or lactation * Use of tobacco * Food sensitivities or allergies to the foods or components of foods provided in the standard meals including gluten, dairy, egg, soy, nuts, or seafood * Use of herbal or plant-based supplements; omega-3 fatty acids, and fish oils in the past 3-6 months, and unwilling to discontinue use while participating in the study. * Use of lipid-lowering, glucose-lowering, anti-hypertensive, or weight loss medications * Use of antibiotics in the last three months.